D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Kelly Services Class A
KELYA
$465M
| $412K | ﹤0.01% |
18,697
-3,135
| -14% | -$69.1K |
|
2127
Peoples Bancorp
PEBO
$1.09B
| $412K | ﹤0.01% |
13,292
+3,641
| +38% | +$113K |
|
2128
AXIS Capital
AXS
$7.59B
| $407K | ﹤0.01% |
7,425
-209,023
| -97% | -$11.5M |
|
2129
EverQuote
EVER
$849M
| $406K | ﹤0.01% |
+54,633
| New | +$406K |
|
2130
Xencor
XNCR
$596M
| $406K | ﹤0.01% |
13,056
-64,229
| -83% | -$2M |
|
|
QHC
2131
DELISTED
Quorum Health Corporation
QHC
| $406K | ﹤0.01% |
289,839
+275,672
| +1,946% | +$386K |
|
2132
United Natural Foods
UNFI
$1.72B
| $404K | ﹤0.01% |
30,555
-3,949
| -11% | -$52.2K |
|
2133
BlueLinx
BXC
$628M
| $401K | ﹤0.01% |
+15,046
| New | +$401K |
|
2134
Winmark
WINA
$1.76B
| $397K | ﹤0.01% |
2,103
+24
| +1% | +$4.53K |
|
2135
Green Plains
GPRE
$635M
| $395K | ﹤0.01% |
+23,700
| New | +$395K |
|
2136
Novanta
NOVT
$4.14B
| $395K | ﹤0.01% |
4,659
-45,978
| -91% | -$3.9M |
|
2137
Dorian LPG
LPG
$1.35B
| $389K | ﹤0.01% |
60,574
-13,261
| -18% | -$85.2K |
|
2138
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $388K | ﹤0.01% |
13,881
+451
| +3% | +$12.6K |
|
2139
First Merchants
FRME
$2.32B
| $388K | ﹤0.01% |
10,518
-28,014
| -73% | -$1.03M |
|
|
VIA
2140
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $386K | ﹤0.01% |
8,676
+4,769
| +122% | +$212K |
|
2141
Ameren
AEE
$26.8B
| $385K | ﹤0.01% |
5,231
-3,861
| -42% | -$284K |
|
2142
Exelon
EXC
$43.8B
| $384K | ﹤0.01% |
10,732
-5,188
| -33% | -$186K |
|
2143
Nordson
NDSN
$12.6B
| $384K | ﹤0.01% |
2,900
-9,435
| -76% | -$1.25M |
|
|
CRZO
2144
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $381K | ﹤0.01% |
+30,549
| New | +$381K |
|
2145
Q2 Holdings
QTWO
$5.13B
| $378K | ﹤0.01% |
5,459
-65,655
| -92% | -$4.55M |
|
|
CVA
2146
DELISTED
Covanta Holding Corporation
CVA
| $377K | ﹤0.01% |
21,792
-38,121
| -64% | -$659K |
|
2147
Bank of New York Mellon
BK
$73.3B
| $376K | ﹤0.01% |
+7,460
| New | +$376K |
|
2148
Element Solutions
ESI
$6.24B
| $376K | ﹤0.01% |
37,259
-195,677
| -84% | -$1.97M |
|
|
RPAI
2149
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $374K | ﹤0.01% |
30,697
-30,041
| -49% | -$366K |
|
2150
Lumen
LUMN
$6.3B
| $373K | ﹤0.01% |
31,088
-126,660
| -80% | -$1.52M |
|